Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
6 evidence topics · 8 sources
Immediate-release capsule, 20 mg: intended commercial dosage
RAPIDe-3 study drug: one soft capsule per dose
Pharmaceutical forms in the EU paediatric investigation plan
Material safety data sheet
No evidence found.